|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Iteos Therapeutics, Inc. (ITOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
37,960,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile iTeos Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of a differentiated immuno-oncology therapeutics for patients. Co.'s product candidate, inupadenant, is designed as a selective small molecule antagonist of the adenosine A2a receptor, in the adenosine pathway, a main driver of immunosuppression in the tumor microenvironment across a range of tumors. Co.'s main antibody product candidate, EOS-448, is an antagonist of T-cell immunoreceptor with Ig and ITIM domains, an immune checkpoint with multiple mechanisms of action leading to immunosuppression.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,000 |
5,000 |
Total Buy Value |
$0 |
$0 |
$41,850 |
$41,850 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
0 |
0 |
350,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$5,692,673 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-11-29 |
4 |
AS |
$34.46 |
$598,543 |
I/I |
(17,356) |
4,953,360 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-11-26 |
4 |
AS |
$35.49 |
$453,110 |
I/I |
(12,674) |
3,029,191 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-11-26 |
4 |
AS |
$35.49 |
$453,110 |
I/I |
(12,674) |
3,029,191 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-11-26 |
4 |
AS |
$35.49 |
$758,282 |
I/I |
(21,210) |
4,970,716 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-11-24 |
4 |
AS |
$35.20 |
$2,206,510 |
I/I |
(60,808) |
4,991,926 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-11-24 |
4 |
AS |
$35.20 |
$1,318,543 |
I/I |
(36,337) |
3,041,865 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-11-23 |
4 |
AS |
$36.21 |
$1,212,340 |
I/I |
(33,476) |
5,052,734 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-11-23 |
4 |
AS |
$36.21 |
$724,449 |
I/I |
(20,004) |
3,078,202 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-11-23 |
4 |
AS |
$36.08 |
$523,160 |
D/D |
(14,500) |
78,200 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-11-22 |
4 |
AS |
$37.16 |
$1,325,817 |
I/I |
(35,333) |
5,086,210 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-11-22 |
4 |
AS |
$37.16 |
$792,271 |
I/I |
(21,114) |
3,098,206 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-11-22 |
4 |
OE |
$12.45 |
$202,474 |
D/D |
16,263 |
92,700 |
|
- |
|
Lager Joanne Jenkins |
Chief Medical Officer |
|
2021-11-18 |
4 |
AS |
$34.50 |
$966,000 |
D/D |
(28,000) |
0 |
|
- |
|
Lager Joanne Jenkins |
Chief Medical Officer |
|
2021-11-18 |
4 |
OE |
$4.30 |
$120,400 |
D/D |
28,000 |
28,000 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-11-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(15,671) |
5,121,543 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-11-17 |
4 |
AS |
$0.00 |
$0 |
I/I |
(15,671) |
3,119,320 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-11-03 |
4 |
AS |
$28.89 |
$175,777 |
D/D |
(6,085) |
76,437 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-11-02 |
4 |
AS |
$28.42 |
$408,920 |
D/D |
(14,391) |
82,522 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-11-01 |
4 |
AS |
$28.00 |
$2,268 |
D/D |
(81) |
96,913 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-10-21 |
4 |
AS |
$28.00 |
$5,488 |
D/D |
(196) |
96,994 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-10-19 |
4 |
AS |
$28.00 |
$5,628 |
D/D |
(201) |
97,190 |
|
- |
|
Mpm Asset Management Investors Bv2018 Llc |
10% Owner |
|
2021-10-18 |
4 |
AS |
$27.14 |
$167,372 |
I/I |
(6,167) |
3,134,991 |
|
- |
|
Mpm Bioventures 2018 Gp Llc |
10% Owner |
|
2021-10-18 |
4 |
AS |
$27.14 |
$167,372 |
I/I |
(6,167) |
3,134,991 |
|
- |
|
Oncology Impact Fund (cayman) Management L.p. |
10% Owner |
|
2021-10-18 |
4 |
AS |
$27.14 |
$280,085 |
I/I |
(10,320) |
5,137,214 |
|
- |
|
Detheux Michel |
Chief Executive Officer |
|
2021-10-15 |
4 |
AS |
$28.01 |
$45,796 |
D/D |
(1,635) |
97,391 |
|
- |
|
229 Records found
|
|
Page 4 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|